Activating BRAF Mutations Detected in Mixed Hürthle Cell Carcinoma and Multifocal Papillary Carcinoma of the Thyroid Gland

2016 ◽  
Vol 24 (6) ◽  
pp. 519-524 ◽  
Author(s):  
Sara Sinno ◽  
Mahmoud Choucair ◽  
Mona Nasrallah ◽  
Lara Wadi ◽  
Mark N. Jabbour ◽  
...  
Thyroid ◽  
2012 ◽  
pp. 120301085144008
Author(s):  
Justin Bishop ◽  
Gaosong Wu ◽  
Ralph P. Tufano ◽  
William H Westra

2015 ◽  
Vol 49 (1) ◽  
pp. 26-31 ◽  
Author(s):  
Nevena Ristevska ◽  
Sinisa Stojanoski ◽  
Daniela Pop Gjorceva

Abstract Background. Hürthle cell neoplasms could be benign (Hürthle cell adenoma) or malignant (Hürthle cell carcinoma). Hürthle cell carcinoma is a rare tumour, representing 5% of all differentiated thyroid carcinomas. The cytological evaluation of Hürthle cell neoplasms by fine needle aspiration biopsy (FNAB) is complicated because of the presence of Hürthle cells in both Hürthle cell adenoma and Hürthle cell carcinoma. Thus, the preoperative distinction between these two entities is very difficult and possible only with pathohistological findings of the removed tumour. Case report. A 57-year old female patient was admitted at our Department, for investigation of nodular thyroid gland. She was euthyroid and FNAB of the nodules in both thyroid lobes were consistent of Hürthle cell adenoma with cellular atypias. After thyroidectomy the histopathology revealed Hürthle cell adenoma with high cellular content and discrete cellular atypias in the left lobe and follicular thyroid adenoma without cellular atypias in the right lobe. One year after substitution therapy, a palpable tumour on the left side of the remnant tissue was found, significantly growing with time, presented as hot nodule on 99mTc-sestamibi scan and conclusive with Hürthle cell adenoma with marked cellularity on FNAB. Tumorectomy was performed and well-differentiated Hürthle cell carcinoma detected. The patient received ablative dose of 100 mCi 131I. No signs of metastatic disease are present up to date. Conclusions. The differences between Hürthle cell adenomas and Hürthle cell carcinomas could be clearly made only by histopathological evaluation. Patients with cytological diagnosis of Hürthle cell neoplasms should proceed to total thyroidectomy, especially if tumour size is > 1cm, FNAB findings comprise cellular atypias and/or multiple bilateral nodules are detected in the thyroid gland.


2019 ◽  
Vol 14 (4) ◽  
pp. 342-346
Author(s):  
Fatemeh Samiee Rad ◽  
Sohayla Farajee ◽  
Erfan Torabi

The most usual form of the endocrine carcinoma is thyroid cancer (TC). In addition to papillary thyroid carcinoma (PTC), recent studies revealed incidence of RET/PTC rearrangement in other tumors, like Hürthle cell carcinoma (HCC) and even in non-carcinomatous disorders like Hashimoto's thyroiditis. Here, we present a case with concurrence of papillary thyroid carcinoma and Hürthle cell carcinoma. A 60-year-old woman referred to our hospital with a mass in her neck. Physical examinations revealed painful swelling in the thyroid. Ultrasonographic examination showed two hypoechoic nodules in the right lobe. Hürthle cell variant papillary carcinoma was suggested in the cytology report of the fine needle aspiration. Permanent histopathological diagnosis was co-existence of papillary thyroid carcinoma and Hürthle cell carcinoma. The patient was asymptomatic in 14 months follow up. Concurrence of papillary carcinoma and Hürthle cell carcinoma is a rare form of thyroid malignancies, with doubtful cytogenetic findings and biological behaviors. The results showed that it is necessary for the surgeons and pathologists to be aware of lesions for the optimal diagnostic and therapeutic interventions. Also, it is vital to follow up patients with the Hashimot’s thyroiditis who have multiple nodules to detect occult thyroid cancers and decide for better therapeutic programs.


Cancer ◽  
2006 ◽  
Vol 106 (8) ◽  
pp. 1669-1676 ◽  
Author(s):  
Ronald A. Ghossein ◽  
David H. Hiltzik ◽  
Diane L. Carlson ◽  
Snehal Patel ◽  
Ashok Shaha ◽  
...  

Cancer ◽  
1986 ◽  
Vol 57 (8) ◽  
pp. 1613-1617 ◽  
Author(s):  
Gady Har-el ◽  
Tuvia Hadar ◽  
Karl Segal ◽  
Rudy Levy ◽  
Jack Sidi

Thyroid ◽  
2012 ◽  
Vol 22 (7) ◽  
pp. 690-694 ◽  
Author(s):  
Justin A. Bishop ◽  
Gaosong Wu ◽  
Ralph P. Tufano ◽  
William H. Westra

Sign in / Sign up

Export Citation Format

Share Document